Blunt Roshawn A. 4
4 · Kronos Bio, Inc. · Filed Nov 15, 2021
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Blunt Roshawn A.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-11-11+41,200→ 41,200 totalExercise: $17.10Exp: 2031-11-10→ Common Stock (41,200 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in three equal annual installments following the date of grant.